Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      ERT Reports First Quarter 2011 Operating Results

      - Revenues of $41.7 million

      - GAAP diluted net income per share of $0.06 / Non-GAAP diluted net income per share of $0.09

      - Bookings of $71.8 million


      News provided by

      ERT

      May 02, 2011, 04:02 ET

      Share this article

      Share this article


      PHILADELPHIA, May 2, 2011 /PRNewswire/ -- eResearchTechnology, Inc. (ERT), (Nasdaq: ERT) a global technology-driven provider of  services and customizable medical devices to biopharmaceutical and healthcare organizations and the market leader for centralized cardiac safety and respiratory efficacy services in drug development, announced today results for the first quarter ended March 31, 2011.  Unless otherwise noted, all comparative numbers refer to changes from the same period a year ago.  The financial results include the results related to CareFusion Research Services (RS) commencing from its date of acquisition on May 28, 2010.

      This press release contains financial measures prepared in accordance with accounting principles generally accepted in the United States ("GAAP") and non-GAAP measures adjusted to exclude the impact of the amortization of the acquired intangibles and other assets and acquisition and other costs related to the RS acquisition and related income tax effects.  A reconciliation of these GAAP and non-GAAP measures is found in the attached "Reconciliation of GAAP to Non-GAAP Information."

      Financial Highlights for the First Quarter of 2011

      • Net revenues were $41.7 million for the first quarter of 2011 compared to $44.9 million for the fourth quarter of 2010 and $21.9 million a year ago.  Revenues from RS were $18.9 million in the first quarter of 2011, compared to $20.0 million in the fourth quarter of 2010.

      • GAAP gross margin percentage was 44.2% in the first quarter of 2011 compared to 43.9% for the fourth quarter of 2010 and 53.8% a year ago.  Non-GAAP gross margin percentage was 48.7% in the first quarter of 2011 compared to 49.0% for the fourth quarter of 2010 and 53.8% a year ago.  

      • GAAP operating income margin percentage was 12.8% in the first quarter of 2011 compared to 11.6% for the fourth quarter of 2010 and 12.6% a year ago.  Non-GAAP operating income margin percentage was 17.3% in the first quarter of 2011 compared to 18.5% for the fourth quarter of 2010 and 16.0% a year ago.

      • GAAP net income was $3.1 million, or $0.06 per diluted share, in the first quarter of 2011 compared to $4.1 million, or $0.08 per diluted share, in the fourth quarter of 2010 and $1.8 million, or $0.04 per diluted share, a year ago.  Non-GAAP net income was $4.5 million, or $0.09 per diluted share, in the first quarter of 2011 compared to $6.1 million, or $0.12 per diluted share, in the fourth quarter of 2010 and $2.2 million, or $0.05 per diluted share, a year ago.

      • Cash flow from operations was $5.0 million in the first quarter of 2011, compared to $17.1 million in the fourth quarter of 2010 and $5.3 million a year ago.

      • Cash and short-term investments totaled $29.7 million at March 31, 2011 compared to $30.4 million on December 31, 2010.  ERT had $21.0 million in long-term debt as of March 31, 2011 and December 31, 2010.

      • New bookings were $71.8 million in the first quarter of 2011 compared to $58.9 million for the fourth quarter of 2010 and $43.3 million a year ago.  

      • The gross book-to-bill ratio was 1.7 in the first quarter of 2011 compared to 1.3 in the fourth quarter of 2010 and 2.0 a year ago.  

      • Backlog was $318.6 million as of March 31, 2011 compared to $302.9 million as of December 31, 2010 and $182.7 million a year ago (which did not include RS).  The annualized cancellation rate was 24.6% in the first quarter of 2011 compared to 16.6% in the fourth quarter of 2010 and 21.3% a year ago.  

      "We are very pleased with the record $71.8 million of bookings reported in this quarter," commented Dr. Joel Morganroth.  "This was driven by strong bookings using our integrated solution, which combines respiratory, cardiac safety, and ePRO to our customers.  Our revenue level was slightly lower than expected due to a large TQT cancellation during the quarter.  We also experienced higher cancellations in our respiratory business as three large studies were terminated by the sponsors.  We managed to moderate our expenses as some of the 2011 planned hiring and other investments were delayed.  Offsetting this was the negative impact of the foreign exchange rate changes, which resulted in a charge of approximately $0.01 per share.   Overall, we believe we are off to a strong start for 2011."

      "I am also very excited to have Dr. Jeffrey Litwin appointed as our new President and Chief Executive Officer as previously announced earlier today," continued Dr. Morganroth.  "Jeff and I have worked together for many years, and he brings knowledge of the clinical research domain that is our core business and also experience in the adjacent markets of Phase IV safety surveillance and healthcare."

      2011 Guidance

      The Company reaffirmed its previously-issued guidance for the full year of 2011.  ERT expects net revenues of between $178 million and $188 million for 2011.  ERT expects GAAP diluted net income per share to be between $0.30 and $0.40 for 2011 and non-GAAP diluted net income per share to be between $0.40 and $0.50 for the same period.   For the second quarter ending June 30, 2011, ERT expects net revenues of between $43.0 million and $46.0 million, GAAP diluted net income per share to be between $0.05 and $0.08 and non-GAAP diluted net income per share to be between $0.08 and $0.11.  

      Use of Non-GAAP Financial Measures

      In addition to GAAP financial measures, ERT uses certain non-GAAP financial measures that exclude charges related to the amortization of the RS acquired intangible and other assets and acquisition and other costs which are related to the RS acquisition, and also their related income tax effects.  ERT believes that these non-GAAP measures are useful to investors because this supplemental information facilitates comparisons of its operations from period to period and to the performance of other companies within its industry and assists in gaining a better understanding of its operating results and future prospects.  ERT views amortization of acquired intangible and other assets related to the RS acquisition, which includes such items as the amortization of acquired customer backlog and technology, as items determined at the time of the acquisition.  While ERT reviews the underlying value of these intangibles regularly for impairment, the amortization is an expense typically not affected by operations during any particular period and does not contribute to the operational performance in any particular period.  ERT regards acquisition and other costs related to its recent acquisition as a cost that does not recur on a regular basis.  

      ERT's non-GAAP effective tax rates differ from its GAAP effective tax rates because of 1) the exclusion of the amortization of acquired intangible and other assets and acquisition and other costs incurred in 2010 related to its recent acquisition of RS, and 2) the income tax effect due to the difference between the GAAP and non-GAAP effective tax rate applied against the GAAP pre-tax income, primarily as a result of the acquisition costs incurred in 2010 not being deductible for income tax purposes.  ERT excludes the impact of these discrete tax items from its non-GAAP income tax provision because it believes they are not indicative of the effective income tax rate of its ongoing business operations.

      Management uses these non-GAAP financial measures, in addition to the measures prepared in accordance with GAAP, as the basis for measuring ERT's operating performance, financial and operating decision-making, development of budgets, and comparing such performance to that of prior periods for the same reasons stated above.  These non-GAAP financial measures are not meant to be considered superior to or a substitute for comparable financial measures prepared in accordance with GAAP.  There are also limitations on the non-GAAP measures, including: 1) these non-GAAP measures do not have standardized meanings and may not be comparable to similar non-GAAP measures used by other companies, 2) acquisition and other costs related to ERT's 2010 acquisition of RS represent actual cash expenditures that are excluded from ERT's non-GAAP measures, and 3) although amortization of acquired intangible and other assets does not directly impact ERT's current cash position, such expense is amortized over their expected economic lives and does represent the declining value of the assets acquired, but this expense is excluded from ERT's non-GAAP measures.  ERT adjusts for these limitations by relying on these non-GAAP measures only as a supplement to its GAAP results.

      Conference Call

      Dr. Morganroth, Dr. Litwin, and Mr. Keith Schneck, the Company's Chief Financial Officer, will hold a conference call to discuss these results.  The conference call will take place at 5:00 PM ET on May 2, 2011.  For the conference call, interested participants should dial 1-800-860-2442 when calling within the United States or 1-412-858-4600 when calling internationally. There will be a playback available as well. To listen to the playback, please call 1-877-344-7529 when calling within the United States or 1-412-317-0088 when calling internationally.  Conference code for playback is 450262. This call is being webcast by MultiVu and can be accessed at ERT's website at www.ert.com. The webcast may also be accessed via the direct link at http://www.videonewswire.com/event.asp?id=78559. The webcast can be accessed for up to one year on either site.  

      About eResearchTechnology, Inc.

      ERT (www.ert.com) is a global technology-driven provider of clinical services and customizable medical devices to biopharmaceutical and healthcare organizations.  It is the market leader for centralized cardiac safety and respiratory efficacy services in drug development and also collects, analyzes and distributes electronic patient reported outcomes (ePRO) in multiple modalities across all phases of clinical research.

      This release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that reflect our current views as to future events and financial performance with respect to our operations.  These statements can be identified by the fact that they do not relate strictly to historical or current facts.  They use words such as "aim," "anticipate," "are confident," "estimate," "expect," "will be," "will continue," "will likely result," "project," "intend," "plan," "believe," "look to" and other words and terms of similar meaning in conjunction with a discussion of future operating or financial performance.  

      These statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements.  Factors that might cause such a difference include: unfavorable economic conditions; our ability to obtain new contracts and accurately estimate net revenues, our positive outlook for future bookings, variability in size, scope and duration of projects and internal issues at the sponsoring client; our ability to successfully integrate the RS or any future acquisitions; competitive factors in the market for our centralized services; changes in the bio-pharmaceutical and healthcare industries to which we sell our solutions; technological development; and market demand.  There is no guarantee that the amounts in our backlog will ever convert to revenue.  Should the economic conditions deteriorate, the cancellation rates that we have historically experienced could increase.  Further information on potential factors that could affect the Company's financial results can be found in ERT's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission.  Guidance is based on management's good faith expectations given current market conditions but that continued or further deterioration of general economic conditions, in addition to other factors cited elsewhere, could result in ERT not achieving the revenue and net income per diluted share guidance provided.

      Forward-looking statements speak only as of the date made.  We undertake no obligation to update any forward-looking statements, including prior forward-looking statements, to reflect the events or circumstances arising after the date as of which they were made.  As a result of these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements included in this release or that may be made in our filings with the Securities and Exchange Commission or elsewhere from time to time by, or on behalf of, us.

      Contact:


      Keith Schneck

      Robert East

      eResearchTechnology, Inc.

      Westwicke Partners, LLC

      215-282-5566

      443-213-0502



      eResearchTechnology, Inc. and Subsidiaries

      Consolidated Statements of Operations

      (in thousands, except per share amounts)

      (unaudited)









      Three Months Ended March 31,



      2010


      2011




      Net revenues:





      Services

      $          14,835


      $          23,977


      Site support

      7,033


      17,722






      Total net revenues

      21,868


      41,699






      Costs of revenues:





      Cost of services

      7,311


      13,156


      Cost of site support

      2,799


      10,123






      Total costs of revenues

      10,110


      23,279






      Gross margin

      11,758


      18,420






      Operating expenses:





      Selling and marketing

      3,408


      4,175


      General and administrative

      4,745


      7,508


      Research and development

      858


      1,383






      Total operating expenses

      9,011


      13,066






      Operating income

      2,747


      5,354

      Foreign exchange gains (losses)

      80


      (1,009)

      Other income (expense), net

      20


      (101)






      Income before income taxes

      2,847


      4,244

      Income tax provision

      1,095


      1,151






      Net income

      $            1,752


      $            3,093






      Net income per share:





      Basic

      $              0.04


      $              0.06


      Diluted

      $              0.04


      $              0.06






      Shares used in computing net income per share:





      Basic

      48,675


      48,896


      Diluted

      48,845


      49,251



      eResearchTechnology, Inc. and Subsidiaries

      Consolidated Balance Sheets

      (in thousands, except share and per share amounts)

      (unaudited)














      December 31, 2010

      March 31, 2011

      ASSETS












      Current assets:






          Cash and cash equivalents


      $                30,343



      $               29,614

          Short-term investments


      50



      50

          Investment in marketable securities


      648



      1,053

          Accounts receivable less allowance for doubtful accounts






               of $515 and $547, respectively


      37,236



      37,179

          Inventory


      4,698



      6,804

          Prepaid income taxes


      1,988



      2,660

          Prepaid expenses and other


      4,393



      5,531

          Deferred income taxes


      3,431



      3,431

              Total current assets


      82,787



      86,322







      Property and equipment, net


      42,615



      45,760

      Goodwill


      71,637



      76,702

      Intangible assets


      17,187



      17,435

      Other assets


      609



      718







                 Total assets


      $              214,835



      $             226,937







      LIABILITIES AND STOCKHOLDERS' EQUITY












      Current liabilities:






          Accounts payable


      $                  7,136



      $                 6,613

          Accrued expenses


      16,162



      12,971

          Deferred revenues


      11,670



      12,657

              Total current liabilities


      34,968



      32,241







      Deferred rent


      2,368



      2,405

      Deferred income taxes


      3,703



      3,888

      Long-term debt


      21,000



      21,000

      Other liabilities


      2,141



      2,235







                 Total liabilities


      64,180



      61,769







      Stockholders' equity:






          Preferred stock-$10.00 par value, 500,000 shares authorized,






               none issued and outstanding


      -



      -

          Common stock-$.01 par value, 175,000,000 shares authorized,






               60,460,782 and 60,661,086 shares issued, respectively


      605



      607

          Additional paid-in capital


      100,441



      101,438

          Accumulated other comprehensive (loss) income


      (1,545)



      8,922

          Retained earnings


      131,037



      134,130

          Treasury stock, 11,589,603 and 11,596,966 shares at cost


      (79,883)



      (79,929)







              Total stockholders' equity


      150,655



      165,168







                 Total liabilities and stockholders' equity


      $              214,835



      $             226,937



      eResearchTechnology, Inc. and Subsidiaries

      Consolidated Statements of Cash Flows

      (in thousands)

      (unaudited)



      Three Months Ended March 31,


      2010


      2011





      Operating activities:




        Net income

      $           1,752


      $           3,093

        Adjustments to reconcile net income to net cash




            provided by operating activities:




                Depreciation and amortization

      2,624


      5,988

                Cost of sales of equipment

      1


      3

                Share-based compensation

      605


      662

                Deferred income taxes

      (160)


      204

                Changes in operating assets and liabilities:




                   Accounts receivable

      1,033


      1,030

                   Inventory

      -


      (1,412)

                   Prepaid expenses and other

      (1,341)


      (1,363)

                   Accounts payable

      539


      91

                   Accrued expenses

      920


      (3,191)

                   Income taxes

      (193)


      (736)

                   Deferred revenues

      (368)


      803

                   Deferred rent

      (145)


      (164)

                       Net cash provided by operating activities

      5,267


      5,008





      Investing activities:




        Purchases of property and equipment

      (3,852)


      (7,254)

        Purchases of investments

      (999)


      -

        Proceeds from sales of investments

      3,716


      -

        Payments for acquisitions

      (203)


      (117)

                       Net cash used in investing activities

      (1,338)


      (7,371)





      Financing activities:




        Proceeds from exercise of stock options

      51


      309

        Stock option income tax benefit

      6


      11

        Repurchase of common stock for treasury

      -


      (46)

                       Net cash provided by financing activities

      57


      274





      Effect of exchange rate changes on cash

      (790)


      1,360





      Net increase (decrease) in cash and cash equivalents

      3,196


      (729)

      Cash and cash equivalents, beginning of period

      68,979


      30,343





      Cash and cash equivalents, end of period

      $         72,175


      $         29,614



      eResearchTechnology, Inc. and Subsidiaries

      Reconciliation of GAAP to Non-GAAP Information

      (in thousands, except per share amounts)

      (unaudited)




      Three Months Ended






      March 31, 2010

      December 31, 2010

      March 31, 2011

      Net revenues

      $              21,868

      $              44,900

      $              41,699





      Reconciliation of GAAP to Non-GAAP gross margin:




      GAAP gross margin

      $              11,758

      $              19,708

      $              18,420

      Amortization of acquired intangibles and other assets

      -

      2,288

      1,878

      Non-GAAP gross margin

      $              11,758

      $              21,996

      $              20,298

      Non-GAAP gross margin percentage

      53.8%

      49.0%

      48.7%





      Non-GAAP gross margin percentage is calculated by dividing non-GAAP gross margin by net revenues








      Reconciliation of GAAP to Non-GAAP




          operating income:




      GAAP operating income

      $                2,747

      $                5,230

      $                5,354

      Amortization of acquired intangibles and other assets

      -

      2,288

      1,878

      Acquisition and integration related costs

      741

      800

      -

      Non-GAAP operating income

      $                3,488

      $                8,318

      $                7,232

      Non-GAAP operating income margin percentage

      16.0%

      18.5%

      17.3%





      Non-GAAP operating income margin percentage is calculated by dividing non-GAAP operating income by net revenues








      Reconciliation of GAAP to Non-GAAP net income:




      GAAP net income

      $                1,752

      $                4,120

      $                3,093

      Amortization of acquired intangibles and other assets

      -

      2,288

      1,878

      Acquisition and integration related costs

      741

      800

      -

      Income tax effect due to Non-GAAP reconciling items
      and other differences between the GAAP and
      Non-GAAP effective tax rate

      (284)

      (1,123)

      (502)

      Non-GAAP net income

      $                2,209

      $                6,085

      $                4,469





      Reconciliation of GAAP to Non-GAAP diluted




          net income per share:




      GAAP diluted net income per share

      $                  0.04

      $                  0.08

      $                  0.06

      Amortization of acquired intangibles and other assets

      -

      0.05

      0.04

      Acquisition and integration related costs

      0.02

      0.01

      -

      Income tax effect due to Non-GAAP reconciling items
      and other differences between the GAAP and
      Non-GAAP effective tax rate

      (0.01)

      (0.02)

      (0.01)

      Non-GAAP diluted net income per share

      $                  0.05

      $                  0.12

      $                  0.09





      Shares used in computing diluted net income per share

      48,845

      49,274

      49,251

      Assumed effective tax rate - Non-GAAP

      35.0%

      29.0%

      27.0%














      Three Months


      Ending June 30, 2011






      Low Range


      High Range

      Reconciliation of GAAP to Non-GAAP




          diluted net income per share guidance:




      GAAP estimate of diluted net income per share

      $                  0.05


      $                  0.08

      Estimated effect on diluted net income per share of:




          Amortization of acquired intangibles and other assets

      0.04


      0.04

          Income tax effect due to Non-GAAP reconciling items
               and other differences between the GAAP and
               Non-GAAP effective tax rate

      (0.01)


      (0.01)

      Non-GAAP estimate of diluted net income per share

      $                  0.08


      $                  0.11





      Shares used in computing estimated diluted net income per
          share

      49,500


      49,500

      Effective tax rate

      27.0%


      27.0%



      SOURCE ERT

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.